RE: Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial.

Torfadottir, Johanna E; Stampfer, Meir J; Mucci, Lorelei A; Giovannucci, Edward L

Torfadottir, Johanna E; Stampfer, Meir J; Mucci, Lorelei A; Giovannucci, Edward L.

Affiliation

Torfadottir JE; Affiliations of authors: Centre of Public Health Sciences, University of Iceland, Reykjavik, Iceland (JET, LAM); Department of Epidemiology (MJS, LAM, ELG) and Department of Nutrition (MJS, ELG), Harvard School of Public Health, Boston, MA; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA (MJS, LAM, ELG).

J Natl Cancer Inst ; 106(4): dju018, 2014 Apr.

Article in En | MEDLINE | ID: mdl-24685929

Subject(s)

Fatty Acids, Omega-3/adverse effects; Fatty Acids, Omega-3/blood; Fatty Acids, Omega-6/blood; Prostatic Neoplasms/diagnosis; Prostatic Neoplasms/epidemiology; Humans; Male

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Prostatic Neoplasms / Fatty Acids, Omega-3 / Fatty Acids, Omega-6 Type of study: Etiology_studies / Risk_factors_studies Language: En Journal: J Natl Cancer Inst Year: 2014 Type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google